
Stereotaxis Bets Billions on Robocath Takeover to Dominate Robotic Cardiology
Stereotaxis acquires Robocath for $20M upfront plus $25M in milestones, targeting $2M first-year revenue and breakeven by year three.
STXSacquisitionregulatory approval








Investing.com··Peter Frank